Newfoundland Diagnostics
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Newfoundland Diagnostics operates in Healthcare & Life Sciences and is based in Amersham. It was founded in 2020.
Newfoundland Diagnostics is a health-testing company that develops and distributes at-home diagnostic test kits for various medical conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, Patient Engagement
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Newfoundland Diagnostics Comparables
Compare Newfoundland Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TestCard | 84% | |
| PocDoc | 79% | |
| BioSure (UK) Ltd | 79% |
For institutional investors. Book with your work email.
Newfoundland Diagnostics Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 117% MoM, reaching 8.8K.
- Jun 22, 2026
Monthly visitors grew 37% MoM, reaching 6.9K.
For institutional investors. Book with your work email.
Newfoundland Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Newfoundland Diagnostics's valuation, stock price, and market status.
Is Newfoundland Diagnostics a public or private company?
Newfoundland Diagnostics is a private company.
What is the current stock price of Newfoundland Diagnostics?
Newfoundland Diagnostics is a private company, so its shares have no public market price. Caplight tracks Newfoundland Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Newfoundland Diagnostics worth (valuation)?
Valuation information for Newfoundland Diagnostics is not publicly available.
Can I buy Newfoundland Diagnostics stock?
Newfoundland Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Newfoundland Diagnostics's last funding round?
Funding round information for Newfoundland Diagnostics is not publicly available.
Who are the main investors in Newfoundland Diagnostics?
Investor information for Newfoundland Diagnostics is not publicly disclosed.
Will Newfoundland Diagnostics IPO soon?
No public IPO plans have been announced for Newfoundland Diagnostics.
How can I track Newfoundland Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Newfoundland Diagnostics's shares on secondary markets.